Skip to main content
SpringerLink
Log in

Heilungschancen besser denn je

Onychomykose: State of the Art

  • Fortbildung
  • Published:
hautnah dermatologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

© Hans-Jürgen Tietz

Abb. 2

© Hans-Jürgen Tietz

Abb. 3

© Hans-Jürgen Tietz

Abb. 4

© Hans-Jürgen Tietz

Literatur

  1. Szepietowski JC et al. Stigmatisation in onychomycosis patients: a population-based study. Mycoses 2009; 52: 343-9

  2. Tietz HJ et al. Onychomykose. Chancen auf Heilung sind besser denn je. Der Deutsche Dermatologe 2018; 66: 36-41

  3. Tietz HJ et al. PCR revolutioniert Diagnostik. Der Deutsche Dermatologe 2020; 68: 688-95

  4. Bongomin F et al. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. J Fungi 2017: 3: 57

  5. Havlickova B et al. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 51 (Suppl. 4): 2-15

  6. Tietz HJ: Sporen und ihre Bedeutung in der Onychomykosetherapie. hautnah dermatologie 2017; 33: 28-30

  7. Hollmig ST et al: Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: a randomized, controlled trial. J Am Acad Dermatol. 2014; 70: 911-7

  8. Bristow IR. The effectiveness of lasers in the treatment of onychomycosis: a systematic review. J Foot Ankle Res 2014; 7: 34

  9. Weber GC et al. Treatment of onychomycosis using a 1064-nm diode laser with or without topical antifungal therapy: a single-center, retrospective analysis in 56 patients. Eur J Med Res 2018; 23: 53

  10. Osborne CS et al. Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine. Antimicrob Agents Chemother 2015; 49: 2840-4

  11. Yamada T et al. Terbinafine resistance of Trichophyton clinical isolates caused by specific point mutations in the Squalene Epoxidase Gene. Antimicrob Agents Chemother. 2017; 61: 115-7

  12. Kano R et al. Trichophyton indotineae sp. nov.: A New Highly Terbinafine-Resistant Anthropophilic Dermatophyte Species. Mycopathologia 2020; 185: 947-58

  13. Seeliger HPR, Seefried L: Aldo Castellani sein Leben und sein Werk. mycoses 1989; 32: 391-397

  14. Weon JL et al. Increasing Prevalence of Trichophyton rubrum Identified through an Analysis of 115,846 Cases over the Last 37 Years. J Korean Med Sci 2015; 30: 639-43

  15. Tietz HJ, Gunkel U. Mykosen bei Kindern und Erwachsenen. Mykosen bei Kindern und Erwachsenen. In: InfectoPharm Arzneimittel und Consilium GmbH. Themenheft 2020; 4

  16. Virchow R. Zur normalen und pathologischen Anatomie der Nägel und der Oberhaut. Verhandl Physikal Med Gesellsch Würzburg. 1854; 5: 83-105

  17. Tietz HJ et al. Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40 % urea: a double-blind, randomized, placebo-controlled multicenter study. Mycoses 2013; 56: 414-21

  18. Stettendorf S et al. Azolderivate enthaltende Formulierungen sowie Ihre Verwendung zur atraumatischen Nagelentfernung. Europäische Patentschrift 1992; 0 204 230 B1

  19. Tietz HJ. Therapie mykotischer und nicht-infektiöser Nagelstörungen mit Mastix aus Pistacia lentiscus, Hyaluronsäure und Silizium. derm 2022; 28: im Druck.

  20. Tietz HJ et al. Modernes Onychomykose-management: Fortschritte in Diagnostik und Therapie. derm 2019; 25: 245-59

  21. Evans EGV et al. Double blind, randomised study comparing continuous terbinafine with intermittent itraconazole in the treatment of toenail onychomycosis. The LION study group. Br Med J 1999; 318: 1031-5

  22. Liu R et al. Itraconazole suppresses the growth of glioblastoma through induction of autophagy. Autophagy 2014; 10: 1241-55

  23. 23. Ahmad Y et al. Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted States. Antimicrob Agents Chemother. 2015; 59: 5681-96

  24. Mayne Pharma International Pty Ltd. Lozanoc 50mg capsules: consumer medicine information. Mayne Pharma International Pty Ltd., South Australia, Australia

  25. Gebrauchsinformation Itraisdin 50 mg Hartkapseln. OP00824F/01/21, letzte Überarbeitung 4/2021

  26. Mayser P. Terbinafin: Medikamenteninduzierter Lupus erythematodes und Triggerung psoriatischer Hautveränderungen. Hautarzt. 2016; 67: 724-31

  27. Tietz HJ et al. Nystatin - hoch wirksam, auch bei Azol-Resistenz. gyne 2021; 42: 61-7

  28. Elewski B et al. Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality. Ther Clin Risk Manag 2005; 4: 299-306

Download references

Author information

Authors and Affiliations

  1. Facharzt für Innere Medizin, mycoclinic/Institut für Pilzkrankheiten, Luisenstr. 50, 10117, Berlin, Deutschland

    Hans-Jürgen Tietz

Authors
  1. Hans-Jürgen Tietz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tietz, HJ. Onychomykose: State of the Art. hautnah dermatologie 38, 40–43 (2022). https://doi.org/10.1007/s15012-022-6843-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15012-022-6843-9

Search

Navigation